Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients
- 1 January 1996
- journal article
- clinical trial
- Published by Springer Nature in Diabetologia
- Vol. 39 (1) , 103-112
- https://doi.org/10.1007/bf00400420
Abstract
Summary The aim of the study was to evaluate an acute decrease in NEFA levels during an oral glucose tolerance test and its effects on glucose tolerance, muscle glucose uptake and muscle indirect calorimetry in ten lean non-insulin-dependent diabetic subjects. Two 75-g oral glucose tolerance tests were performed in random order. Placebo or 250 mg acipimox (to inhibit lipolysis) were administered orally 2 h before the start of the oral glucose tolerance test. Two hours after acipimox administration (time 0), non-esterified fatty acid, glycerol and 3-hydroxybutyrate levels decreased by 84, 68 and 77% respectively, compared to basal levels. Concomitantly, muscle lipid oxidation and non-oxidative glycolysis also decreased significantly. After placebo administration, non-esterified fatty acids, glycerol and 3-hydroxybutyrate and lipid oxidation increased by 29, 28, 106 and 33%, respectively (NS vs basal levels; p<0.001 vs acipimox). There was a negative rate of net glucose storage (interpreted as glycogenolysis) during post-absorptive conditions and at time 0 after administration of both drugs. After oral glucose tolerance test, the incremental areas of blood glucose and insulin were significantly decreased by 18 and 19% after acipimox compared to placebo. In addition, the ratio between the incremental area of forearm muscle glucose uptake and the insulin levels was significantly increased by 45% during acipimox compared to placebo administration. Glucose oxidation and non-oxidative glycolysis were significantly higher while lipid oxidation was significantly lower after acipimox than after placebo. In conclusion, our study found that in lean non-insulin-dependent diabetic subjects, an acute decrease in non-esterified fatty acid levels improves glucose tolerance, muscle glucose uptake, glucose oxidation and non-oxidative glycolysis, but is unable to normalize glucose storage.Keywords
This publication has 47 references indexed in Scilit:
- Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1994
- Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3- day intensified treatment periodJournal of Clinical Endocrinology & Metabolism, 1994
- Interaction between glucose and free fatty acid metabolism in human skeletal muscle.Journal of Clinical Investigation, 1993
- Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1992
- Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1991
- Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1990
- Metabolic basis of obesity and noninsulin-dependent diabetes mellitusDiabetes/Metabolism Research and Reviews, 1988
- Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load.Journal of Clinical Investigation, 1988
- Blood Glucose, Lactate, Pyruvate, Glycerol, 3-Hydroxybutyrate and Acetoacetate Measurements in Man Using a Centrifugal Analyser with a Fluorimetric Attachmentcclm, 1988
- Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism.Journal of Clinical Investigation, 1987